Brodsky & Smith LLC has announced investigations into whether the boards of Esperion Therapeutics, Sila Realty Trust, Lisata Therapeutics, and SkyWater Technology breached their fiduciary duties to shareholders during recent merger agreements. The investigations focus on whether these boards conducted fair processes and offered fair value to shareholders in the deals. These mergers involve cash and stock transactions with values ranging from $3.16 to $35 per share. Investors holding shares in these companies are encouraged to contact Brodsky & Smith for more information, with no cost or obligation involved.
The Global X Russell 2000 Covered Call ETF (RYLD) provides a high monthly yield of 11.9% and achieved a 20.5% total return over the past year. However, its strategy involving at-the-money options causes structural net asset value (NAV) erosion and ca...
A Cambridge study found Ethereum's annual energy consumption at 7.87 gigawatt-hours, making it the second-least energy-intensive proof-of-stake (PoS) blockchain when adjusted for market value. This marks a significant improvement from its previous pr...
The IBIT Bitcoin ETF, managed by BlackRock, recorded a $292 million net inflow last week, reversing eight consecutive weeks of outflows. This inflow reflects renewed institutional interest in Bitcoin, which currently trades near $70,000. Market confi...
After a 72% price drop, XRP has reached extreme bearish sentiment, with heavy short interest and negative funding rates on Binance. Analysts like Crypto Patel see this as a contrarian buy signal, noting past rebounds of over 100% after similar condit...
Frontline plc, a leading crude oil tanker company, is rated a Strong Buy with a $52 price target, suggesting a 42% potential gain from current prices. The company has secured 82% of its VLCC tanker days at a high rate of $181,700 per day for Q2, supp...
